Autor: |
Takahiro Kitsuka, Fuga Takahashi, James Reinhardt, Tatsuya Watanabe, Anudari Ulziibayar, Asigul Yimit, John Kelly, Toshiharu Shinoka |
Jazyk: |
angličtina |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Bioengineering, Vol 9, Iss 11, p 696 (2022) |
Druh dokumentu: |
article |
ISSN: |
2306-5354 |
DOI: |
10.3390/bioengineering9110696 |
Popis: |
Tissue engineering has paved the way for the development of artificial human cardiac muscle patches (hCMPs) and cardiac tissue analogs, especially for treating Myocardial infarction (MI), often by increasing its regenerative abilities. Low engraftment rates, insufficient clinical application scalability, and the creation of a functional vascular system remain obstacles to hCMP implementation in clinical settings. This paper will address some of these challenges, present a broad variety of heart cell types and sources that can be applied to hCMP biomanufacturing, and describe some new innovative methods for engineering such treatments. It is also important to note the injection/transplantation of cells in cardiac tissue engineering. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|